- Open Access
- Open Peer Review
Charcot arthropathy of the diabetic foot in a sub-Saharan tertiary hospital: a cross-sectional study
Journal of Foot and Ankle Research volume 12, Article number: 33 (2019)
Charcot foot arthropathy is a potentially limb-threatening condition that leads to progressive destruction of the bones and joints in the neuropathic foot. One of its main causes is diabetes mellitus whose prevalence is steadily increasing. The acute phase is often misdiagnosed thus leading to foot deformity, ulceration and increased risk of amputation. There is a paucity of literature on this condition from sub-Saharan Africa. This study aimed at determining the extent of Charcot foot arthropathy, the radiological patterns of Charcot foot arthropathy and patient’s factors associated with Charcot foot arthropathy among adult patients with longstanding diabetes in an African setting.
This was a cross-sectional study that was carried at a national referral and university teaching hospital in Kampala, Uganda. One hundred patients with longstanding diabetes mellitus were consecutively recruited. Patients with a history of having diabetes mellitus for at least seven years since diagnosis were considered to have a longstanding disease. Clinical assessment of both feet was done. Weight-bearing radiographs of the selected foot were taken and evaluated using the Sanders and Frykberg and modified Eichenholtz classifications. A blood sample was taken for glycosylated haemoglobin (HbA1c). Data were summarized using descriptive statistics and student t-test.
The proportion of Charcot foot arthropathy among patients with longstanding diabetes was 12% of which one-third (4 out of 12) were acute cases. Fifty percent of the lesions were in the forefoot and 50% in the midfoot. Seventeen percent of lesions were at the inflammatory stage of the modified Eichenholtz classification, 50% at the developmental stage, 25% at the healing stage, and 8% at the remodelling stage. An abnormal foot radiograph was significantly associated with Charcot foot arthropathy among patients with longstanding diabetes.
Charcot foot arthropathy is fairly common in patients with longstanding diabetes mellitus in these settings with one third of patients presenting in the early acute phase. An abnormal weight-bearing radiograph was an associated factor of Charcot foot arthropathy among this specific group of patients. To reduce on the morbidity and limb threatening sequelae of this condition, clinicians are therefore advised to routinely examine the feet of patients with diabetes and send those with suspicious signs and symptoms for radiographic assessment.
Diabetes mellitus is the most prevalent non-communicable chronic disease worldwide , with Africa having the highest prevalence of undiagnosed diabetes . The prevalence of diabetes mellitus in Uganda is on the increase and it is becoming a major public health problem that is being compounded by limited access to quality health care [3,4,5,6]. Population-based studies in Uganda have reported diabetes prevalence rates ranging from 1.4 to 7.4% [3, 7]. Diabetes mellitus predisposes patients to foot complications that range from ulceration to gangrene that is associated with significant long-term disability and premature mortality . Complication rates for foot complications in Africa vary from 4 to 19%; peripheral neuropathy, 4–84.4%; peripheral vascular disease, 2.9–78.7%; gangrene, 0.6–69%; and amputation rates of 0.3–45% . However, very few studies from Africa have specifically addressed Charcot foot arthropathy (CA).
Charcot foot arthropathy (CA), is a condition affecting the bones and joints of the foot in patients with peripheral neuropathy of various origins, characterized in the earliest phase by non-infective inflammation of bones and joints of the foot [8,9,10] and in the later phases by progressive destruction of bones and joints in the weight-bearing neuropathic foot leading to acute fractures, dislocations and joint destruction [11, 12]. There are many reported aetiologies of CA, however, nowadays diabetes mellitus has become the leading cause [8, 12,13,14,15].
Globally, several population-based studies have reported an estimated CA prevalence ranging from 0.08% of the general diabetes patient population to 13% of patients presenting at diabetic foot clinics [12, 14, 16, 17] though the exact prevalence of CA is unknown. This might partly be attributed to a high incidence of mistaken or delayed initial diagnosis [12, 14, 16]. Charcot foot arthropathy is associated with several complications [18, 19] yet there is a paucity of literature on CA from sub-Saharan Africa. We came across only one study from East Africa that was conducted in a Kenyan district hospital and reported foot complication rates as high as 29.2% in patients attending a diabetic clinic; with 95% of these having diabetic ulcers and 5% had CA or cellulitis . To the best of the author’s knowledge, no study related to CA in Uganda has yet been published.
The acute phase of CA is often misdiagnosed and can lead to permanent foot deformity, ulceration thus increasing the risk of lower extremity amputation [8, 12, 21, 22]. Early diagnosis and management of acute CA are therefore imperative to avoid progression towards permanent foot deformity and its associated complications [12, 13]. In patients with diabetes and an established CA, patients can present with foot ulceration secondary to foot deformity and therapeutic efforts tend to be focused on ulcers management rather than arresting the disease process .
There are 3 types of Charcot foot classification: clinical, anatomical and radiological [11, 12, 17, 24,25,26]. In clinical practice, Charcot foot can be classified into the acute and chronic stage :
In the acute stage, the foot is remarkably red, warm and swollen; the midfoot is most affected and pain is not a prominent feature . In the Chronic stage signs of local inflammation progressively recede [25, 27]; stable deformities may develop in this stage most commonly a rocker bottom deformity [25, 27]. The most frequently used anatomical classification was proposed by Sanders and Frykberg [11, 12, 17, 24,25,26]. It describes five different patterns of destruction. The radiological classification is based on the natural history of the disease and is divided into four stages based on Eichenholtz’s work in 1966, and later modified in 1990 by Shibata et al. [17, 24,25,26,27,28].
Potential risk factors associated with CA include age, duration of diabetes, body mass index, history of an instigating event such as foot trauma or foot surgery and peripheral neuropathy [11, 12, 14, 29, 30]. In patients with diabetes, CA typically presents during the fifth or sixth decade of life . A longstanding history, at least a decade with diabetes is usual [32,33,34]. Most commonly, at the time of onset patients with both Type 1 and Type 2 diabetes have been diagnosed for a period ≥10 years, however, for type 2 other studies found a diabetes duration of 5 to 9 years at the time of CA diagnosis [11, 12, 14, 29, 30]. The mean body mass index of Charcot patients, according to Pakarinen et al.  was 32.9 kg/m2 and 34.5 kg/m2 in men and women, respectively. A history of an instigating event (foot trauma, foot surgery) preceding the onset of Charcot's foot has been reported from 22 to 73% of the time . Peripheral neuropathy is associated with all disorders that produce neuroarthropathy and is believed to be the prerequisite for the development of Charcot arthropathy, however not all patients with diabetes and peripheral neuropathy will develop Charcot foot arthropathy [8, 14, 17, 29, 30].
The prevalence of diabetes mellitus is currently increasing worldwide including Uganda, becoming, therefore, a major public health problem [3,4,5]. If not managed in time, CA leads to permanent foot deformities, which will progress to foot ulcers, thus increasing the risk for lower extremity amputation. Charcot foot arthropathy is a contributing factor in the 15 to 40-fold increase in the risk of lower-extremity amputations in the population with diabetes . Screening for diabetic complications in Uganda urban diabetic clinics is suboptimal . Among patients with diabetes, peripheral neuropathy, the main risk factor of CA estimated to have a prevalence of 9 to 32% among patients with diabetes [14, 38, 39], was found to be 46.4% in Uganda at the time of diagnosis .
Despite the facts mentioned above, there was no baseline data in terms of extent and patterns of that foot disease in these clinics, there were no established protocol for its early diagnosis and management. Charcot foot arthropathy is overlooked and misdiagnosed; hence the increased morbidity increased risk of foot amputations and high economic burden among these patients.
Therefore, this study aimed at determining the extent of CA, the radiological patterns of CA and patient’s factors associated with CA among adult patients with longstanding diabetes attending MNRH.
This was a cross-sectional study that was conducted from June 2017 to April 2018.
The study was carried out in the weekly diabetic outpatient clinic at Mulago National Referral Hospital (MNRH). Mulago hospital, located in the Ugandan capital city Kampala, is the largest national referral hospital in the country and is also the teaching hospital for Makerere University.
Participants included adult patients (at least 18 years) with long-standing diabetes mellitus who gave written informed consent. For this study, patients with a history of having diabetes mellitus for at least seven years since diagnosis were considered to have a longstanding disease. Patients with gangrene of the foot were excluded. Participants were consecutively recruited from a diabetic outpatient clinic. The sample size was 100 patients. We used an assumed prevalence of 7% based on Frykberg et al.  study that reported a CA prevalence of 0.08–13% and a precision of 5% (delta). To allow for adequate power, a confidence level of 95% was selected.
Adult patients with long-standing diabetes were consented and consecutively enrolled in the study. Data collected on history included demographic characteristics, duration since diagnosis of diabetes mellitus, and previous foot surgery or foot trauma. Clinical assessment was done for both feet after which one foot, the most affected, was selected for a weight-bearing foot radiographs. The feet were examined for swelling, deformity, ulceration, peripheral neuropathy and warmth. Foot ulcers were examined to rule out osteomyelitis which was clinically suspected if the ulcer had been present for more than one week, the lesion extending more than 2cm2, and a positive probe to bone test. The probe to bone test was considered positive if the bone could be felt using a sterile blunt metallic probe through the ulcer [9, 40].
Peripheral neuropathy was assessed using the 5.07/10 g Semmes-Weinstein monofilament to test for sensation on the plantar aspect of the first, third, and fifth metatarsal heads. The monofilament was applied to the test site perpendicularly until it bent for about one second. The patients were instructed to say “yes” each time they sensed the monofilament. If the patient failed to sense the monofilament after bending, the test site was considered to be insensate. Patients unable to detect touch at one or more sites were considered to have abnormal sensation. Only patients able to feel all the examination sites were considered to have a normal sensation. [41,42,43,44,45]. The warmth was assessed using a handheld infrared dermal thermometer (Elektro™ Orb Genesis LLC, Istanbul, Turkey). The temperature was taken on the dorsal aspect of the midfoot or the most prominent site of the swelling. A difference of more than 2 °C between the two feet implied the presence of local inflammation, raising suspicion of the acute phase CA.
Sanders and Frykberg anatomical classification:
|Type / Pattern||Anatomic location|
|Pattern I||Forefoot (metatarsophalangeal and interphalangeal joints)|
|Pattern II||Tarso-metatarsal joints|
|Pattern III||Talonavicular, naviculocuneiform, and calcaneocuboid joints|
|Pattern IV||Ankle and subtalar joints|
Modified Eichenholtz classification:
|Stage||Clinical findings||Radiological findings|
|Localized warmth, oedema/swelling and erythema||Almost normal or minimal abnormality|
|Marked localized swelling, warmth, and redness; minor bone deformity, joint instability (ligamentous laxity).||Focal bone demineralization (osteopenia). Bony debris at articular margins. Fragmentation of subchondral bone. Periarticular fracture. Subluxation, and/or dislocation.|
|Continued but decreased warmth, oedema and erythema, major bone deformity, bone instability||Absorption of fine osseous debris. Coalescence/fusion of bone fragments. Callus formation and/or new periosteal bone formation. Sclerosis of bone ends.|
|No warmth, swelling, redness, fixed bone deformity, joint stiffness||Appearance of a mature fracture callus. Bony remodelling of major fragments. Decreased sclerosis (rounding of bone ends) signify the finality of the permanent deformity|
Laboratory tests included glycosylated haemoglobin (HbA1C) for all research participants. For patients with clinical signs of suspected chronic foot osteomyelitis, total white blood cell count and Erythrocyte sedimentation rate (ESR) were as well requested. HbA1c was considered within the normal range if less than 7%. ESR of more than 70 mm/hr. was considered positive for osteomyelitis .
A final diagnosis of Charcot foot arthropathy was made by the PI based on both clinical findings and radiological findings. Three types of conclusion could arise from the examination: Acute CA, Chronic CA, CA associated with osteomyelitis.
Findings leading to confirmation of the diagnosis of acute CA should have all the followings: On observation: foot swelling/oedema/erythema, no single scratch, wound or ulcer. On neurologic examination: reduced or no foot sensation confirmed by a positive 5.07/10 g Semmes-Weinstein monofilament (peripheral neuropathy). On temperature examination: a difference of more than 2 °C with the opposite foot using an infrared dermal thermometer. On foot radiograph: normal radiograph or minimal abnormality different from the one of stages 1 (bony debris, fragmentation, fracture), 2 (coalescence, callus) and 3 (remodeling) of the modified Eichenholtz classification.
Findings leading to confirmation of Chronic CA should have all the followings: On observation: No or reduced swelling/oedema/erythema; no single scratch, wound or ulcer; bone deformity of various degrees. On neurologic examination: reduced or no foot sensation confirmed by a positive 5.07/10 g Semmes-Weinstein monofilament (peripheral neuropathy). On temperature examination: no difference of more than 2 °C with the opposite foot using an infrared dermal thermometer. On foot radiograph: abnormal radiograph showing one of the lesions of stages 1 (bony debris, fragmentation, fracture), 2 (coalescence, callus) or 3 (remodeling) of the modified Eichenholtz classification.
Findings leading to confirmation of the diagnosis of CA associated with osteomyelitis should have all the followings: the presence of a foot ulcer which had been present for more than one week, the lesion extending more than 2cm2, and a positive probe to bone test. On neurologic examination: reduced or no foot sensation confirmed by a positive 5.07/10 g Semmes-Weinstein monofilament (peripheral neuropathy). On foot radiograph: abnormal radiograph showing one of the lesions of stages 1 (bony debris, fragmentation, fracture), 2 (coalescence, callus) or 3 (remodeling) of the modified Eichenholtz classification plus other lesions of osteomyelitis. On laboratory investigation: an ESR more than 70 mm/h.
Data were summarized using descriptive statistics. Bivariate analysis was performed using student t-test for continuous variables and Ranksum Mann Whitney U test categorical variables. A value of less than 0.05 was considered to be associated with CA.
One hundred adult patients with longstanding diabetes were recruited of which the majority were female (79/100, 79%) and a half was above 50 years of age. Sixty–four patients (64%) were either overweight or obese. Forty-three patients (43%) had suffered from diabetes mellitus for more than 10 years. The mean diabetes duration, mean body mass index and mean HbA1c were respectively 12.8 years (± 5.9 SD), 27.6 (± 5.2 SD) and 6.7% (± 6.7 SD). Patient demographic characteristics are summarized in Table 1.
Clinical and radiological assessment
Twelve patients (12%, 7–20 95% CI) were diagnosed with Charcot foot arthropathy, one-third of which had the acute disease on clinical examination.
Using the Sanders and Frykberg anatomical classification of Charcot foot arthropathy, 2 among the 12 participants with CA had normal radiographs, 5 out of the remaining 10 participants (50%) had type 1 and 5 (50%) had type 3 disease.
Using the modified Eichenholtz classification, 2 out of 12 participants with CA (17%) had stage 0 lesions, 6 out of 12 participants with CA (50%) had stage 1 lesions, 3 out of 12 participants with CA (25%) had stage 2 lesions, and 1 out of 12 participants with CA (8%) had stage 3 lesions (Fig. 1).
Patient factors associated with Charcot foot arthropathy
Bivariate analysis of demographic characteristics showed no association between demographic characteristics (age, BMI, diabetes duration) and CA (Table 2).
Bivariate analysis of clinical and paraclinical characteristics showed that an abnormal foot radiograph was associated with CA (Table 3).
This study aimed to determine the extent, the radiological patterns and associated factors of CA among adult patients with longstanding diabetes mellitus attending an outpatient’s clinic in an African setting.
The majority of participants with CA were in their sixth decade of life. This is in concordance with other studies where CA presents during the fifth and sixth decade [14, 29, 30]. Age is an important risk factor for diabetic neuropathy  which is very crucial in the pathogenesis of CA [8, 14, 17, 29, 30].
The proportion of CA among patients with longstanding diabetes in this study was 12%. Several authors have reported varying prevalence rates for CA in different populations ranging from 0.08% to 13 [12, 14, 17, 23, 26]. The prevalence is low when considering the general population with diabetes and increases when considering a specific group among patients with diabetes such as those consulting a foot clinic for a foot problem [14, 17]. Charcot foot arthropathy is not a frequent complication in the general population with diabetes; however, when present it affects the quality of life, threatens the lower limb for amputation and its management is challenging [23, 26]. Routine examination of the feet is very crucial for patients with diabetes because it can avert catastrophic complications. One-third of the participants in this study were in the acute phase of CA. Diagnosis of CA in the acute phase is difficult because clinical features are non-specific and foot radiographs are often normal. Making a diagnosis at this stage reduces morbidity and facilitates proper management [8, 12, 17, 23]. Clinicians should not only have a clear understanding of diabetic foot disease but should also have a high index of suspicion.
In this study, there was an equal distribution of CA in the fore- and mid-foot. This pattern is similar to what has been reported by other authors [14, 23]. In addition to diabetes, the pattern of disease is influenced by other biomechanical factors that act on the foot. For example, a high BMI predisposes the middle arch to collapse culminating in a rocker-bottom foot; tightness of the triceps surae complex leads to abnormal plantar pressure distribution in the forefoot during walking thus exposing the forefoot bones to more strain [8, 17, 23]. Hence, addressing the biomechanics of the foot is also important in the management of these patients [8, 17, 23, 47,48,49].
Most of the lesions in this study were at the initial stages of the natural history of CA. The mainstay in the treatment of the initial stages (inflammatory and developmental) is non-operative management by offloading the limb in a total contact cast [17, 23, 50]. If these stages are treated judiciously, the achievement of a stable foot without surgery or skin breakdown is possible . This shows the need for quick management intervention in the acute phase before latter stages where bone deformities are fixed and permanent, predisposing the foot to ulceration, infection and high risk of amputation . Clinical symptoms in the inflammatory stage may precede radiographic changes by up to 1 year, hence treatment in this stage is critical in preventing the disease from progressing in further stages [14, 51].
The vast majority of patients in this study had abnormal weight-bearing foot radiographs with no obvious history of trauma. An abnormal weight-bearing foot radiograph in a patient with longstanding diabetes and peripheral neuropathy should raise suspicion of CA. When reading the film one must take time to confirm if the lesions seen are features of CA. Therefore clinicians should have a high index of suspicion and ought to routinely assess patient’s feet for CA.
Strengths and limitations
This study was based on primary data gathered prospectively, hence allowing us to collect all intended parameters. To our knowledge this study is the first on CA in these settings, giving baseline data for further researches and planning in this field. This study also highlights the utility of corroborating clinical information with simple imaging techniques in making a diagnosis. This is especially important in settings, which only have basic diagnostic equipment; and disease diagnosis requires a high index of suspicion and good clinical acumen.
Results of this study may not be generalizable because of the cross-sectional design, relatively small sample size and the use of a consecutive sampling technique. We did not have access to more advanced imaging modality such as MRI to confirm acute cases of CA with normal foot radiographs.
Charcot foot arthropathy is a relatively common complication among patients with long-standing diabetes mellitus in our setting. Several cases present in the acute phase when there are no obvious pathological radiographic changes and diagnosis is relatively difficult. This notwithstanding, the majority of patients with a clinical diagnosis of CA may present with abnormal weight-bearing foot radiographs with the involvement of the mid-foot and forefoot. Therefore clinicians should have a high index of suspicion to enable early diagnosis and also prevent potentially disabling complications.
Availability of data and materials
The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.
Charcot foot arthropathy
Erythrocyte sedimentation rate
Mulago national referral hospital
Abbas Z, Archibald L. Epidemiology of the diabetic foot in Africa. Med Sci Monit. 2005;11(8):RA262–70.
Gelband H, Miller-Petrie M, Pant S, Gandra S, Levinson J, Barter D, White A, Laxminarayan R. Saving diabetic feet in Africa: Cape Town action declaration 2016: diabetes. Wound Healing Southern Africa. 2016;9(1):52–3.
Mayega RW, Guwatudde D, Makumbi F, Nakwagala FN, Peterson S, Tomson G, Ostenson C-G. Diabetes and pre-diabetes among persons aged 35 to 60 years in eastern Uganda: prevalence and associated factors. PLoS One. 2013;8(8):e72554.
Control CfD. Prevention: National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States, vol. 201. Atlanta: US Department of Health and Human Services, Centers for Disease Control and Prevention 2011; 2011. p. 1.
Nambuya A, Otim M, Whitehead H, Mulvany D, Kennedy R, Hadden D. The presentation of newly-diagnosed diabetic patients in Uganda. Qjm. 1996;89(9):705–12.
Hjelm K, Atwine F. Health-care seeking behaviour among persons with diabetes in Uganda: an interview study. BMC Int Health Hum Rights. 2011;11(1):11.
Bahendeka S, Wesonga R, Mutungi G, Muwonge J, Neema S, Guwatudde D. Prevalence and correlates of diabetes mellitus in Uganda: a population-based national survey. Tropical Med Int Health. 2016;21(3):405–16.
Rogers LC, Frykberg RG, Armstrong DG, Boulton AJ, Edmonds M, Van GH, Hartemann A, Game F, Jeffcoate W, Jirkovska A. The Charcot foot in diabetes. Diabetes Care. 2011;34(9):2123–9.
Giurato L, Uccioli L. The diabetic foot: Charcot joint and osteomyelitis. Nucl Med Commun. 2006;27(9):745–9.
Jeffcoate W. The definition of acute Charcot foot. The Diabetic Foot. 2004;7(4):178–82.
Frykberg RG, Zgonis T, Armstrong DG, Driver VR, Giurini JM, Kravitz SR, Landsman AS, Lavery LA, Moore JC, Schuberth JM. Diabetic foot disorders: a clinical practice guideline (2006 revision). The journal of foot and ankle surgery. 2006;45(5):S1–S66.
Milne TE, Rogers JR, Kinnear EM, Martin HV, Lazzarini PA, Quinton TR, Boyle FM. Developing an evidence-based clinical pathway for the assessment, diagnosis and management of acute Charcot neuro-Arthropathy: a systematic review. Journal of foot and ankle research. 2013;6(1):1.
Lowery NJ, Woods JB, Armstrong DG, Wukich DK. Surgical management of Charcot neuroarthropathy of the foot and ankle: a systematic review. Foot & ankle international. 2012;33(2):113–21.
Frykberg RG, Belczyk R. Epidemiology of the Charcot foot. Clin Podiatr Med Surg. 2008;25(1):17–28.
Richard J-L, Almasri M, Schuldiner S. Treatment of acute Charcot foot with bisphosphonates: a systematic review of the literature. Diabetologia. 2012;55(5):1258–64.
Leung H, Ho Y, Wong W. Charcot foot in a Hong Kong Chinese diabetic population. Hong Kong Med J. 2009;15(3):191–5.
Wukich DK, Sung W. Charcot arthropathy of the foot and ankle: modern concepts and management review. J Diabetes Complicat. 2009;23(6):409–26.
Chapman Z, Shuttleworth CMJ, Huber JW. High levels of anxiety and depression in diabetic patients with Charcot foot. Journal of foot and ankle research. 2014;7(1):22.
Al-Rubeaan K, Al Derwish M, Ouizi S, Youssef AM, Subhani SN, Ibrahim HM, Alamri BN. Diabetic foot complications and their risk factors from a large retrospective cohort study. PLoS One. 2015;10(5):e0124446.
Obimbo M, Bundi P, Collis F. Foot complications among diabetics attending a district hospital in Kenya: predisposing factors and possible intervention. Annals of African Surgery. 2008;2(1):3-8.
Game F, Catlow R, Jones G, Edmonds M, Jude E, Rayman G, Jeffcoate W. Audit of acute Charcot’s disease in the UK: the CDUK study. Diabetologia. 2012;55(1):32–5.
Wukich D, Sung W, Wipf S, Armstrong DG. The consequences of complacency: managing the effects of unrecognized Charcot feet. Diabet Med. 2011;28(2):195–8.
Rajbhandari S, Jenkins R, Davies C, Tesfaye S. Charcot neuroarthropathy in diabetes mellitus. Diabetologia. 2002;45(8):1085–96.
Rogers LC, Bevilacqua NJ. The diagnosis of Charcot foot. Clin Podiatr Med Surg. 2008;25(1):43–51.
Papanas N, Maltezos E. Etiology, pathophysiology and classifications of the diabetic Charcot foot. Diabet Foot Ankle. 2013;4. https://doi.org/10.3402/dfa.v4i0.20872
Rogers LC, Frykberg RG. The charcot foot. Med Clin N Am. 2013;97(5):847–56.
Gouveri E, Papanas N. Charcot osteoarthropathy in diabetes: a brief review with an emphasis on clinical practice. World J Diabetes. 2011;2(5):59–65.
Nielson DL, Armstrong DG. The natural history of Charcot’s neuroarthropathy. Clin Podiatr Med Surg. 2008;25(1):53–62.
Nóbrega MBM, Aras R, Netto EM, Couto RD, Marinho AMN, JLd S, Colares VNQ, Campelo PL, Nunes MAL. Risk factors for Charcot foot. Archives of endocrinology and metabolism. 2015;59(3):226–30.
Fauzi AA, Chung TY, Latif LA. Risk factors of diabetic foot Charcot arthropathy: a case-control study at a Malaysian tertiary care Centre. Singap Med J. 2016;57(4):198.
Nehring P, Mrozikiewicz-Rakowska B, Maroszek P, Sobczyk-Kopcioł A, Krzyżewska M, Płoski R, Karnafel W. Risk factors of charcot neuroarthropathy development in patients with type 2 diabetes. Exp Clin Endocrinol Diabetes. 2014;122(01):31–4.
Pakarinen T-K, Laine H-J, Honkonen S, Peltonen J, Oksala H, Lahtela J. Charcot arthropathy of the diabetic foot. Current concepts and review of 36 cases. Scand J Surg. 2002;91(2):195–201.
Lee L, Blume PA, Sumpio B. Charcot joint disease in diabetes mellitus. Ann Vasc Surg. 2003;17(5):571–80.
Fabrin J, Larsen K, Holstein PE. Long-term follow-up in diabetic Charcot feet with spontaneous onset. Diabetes Care. 2000;23(6):796–800.
Jeffcoate WJ. Charcot neuro-osteoarthropathy. Diabetes Metab Res Rev. 2008;24(S1):S62–5.
Foltz KD, Fallat LM, Schwartz S. Usefulness of a brief assessment battery for early detection of Charcot foot deformity in patients with diabetes. The Journal of foot and ankle surgery. 2004;43(2):87–92.
Kibirige D, Atuhe D, Sebunya R, Mwebaze R. Suboptimal glycaemic and blood pressure control and screening for diabetic complications in adult ambulatory diabetic patients in Uganda: a retrospective study from a developing country. Journal of Diabetes & Metabolic Disorders. 2014;13(1):1.
Pinzur MS. Current concepts review: Charcot arthropathy of the foot and ankle. Foot & ankle international. 2007;28(8):952–9.
Mascarenhas JV, Jude EB. The Charcot foot as a complication of diabetic neuropathy. Current diabetes reports. 2014;14(12):1–9.
Dalla Paola L. Confronting a dramatic situation the Charcot foot complicated by osteomyelitis. Int J Low Extrem Wounds. 2014;13(4):247–62.
Tan LS. The clinical use of the 10g monofilament and its limitations: a review. Diabetes Res Clin Pract. 2010;90(1):1–7.
Miranda-Palma B, Sosenko J, Bowker J, Mizel M, Boulton A. A comparison of the monofilament with other testing modalities for foot ulcer susceptibility. Diabetes Res Clin Pract. 2005;70(1):8–12.
Feng Y, Schlösser FJ, Sumpio BE. The Semmes Weinstein monofilament examination as a screening tool for diabetic peripheral neuropathy. J Vasc Surg. 2009;50(3):675–82 e671.
Modawal A, Fley J, Shukla R, Rudawsky D, Welge J, Yang J. Use of monofilament in the detection of foot lesions in older adults. The Journal of foot and ankle surgery. 2006;45(2):76–81.
Jayaprakash P, Bhansali A, Bhansali S, Dutta P, Anantharaman R, Shanmugasundar G, Ravikiran M. Validation of bedside methods in evaluation of diabetic peripheral neuropathy. Indian J Med Res. 2011;133(6):645.
Vinik AI, Nevoret M-L, Casellini C, Parson H. Diabetic neuropathy. Endocrinol Metab Clin. 2013;42(4):747–87.
Hastings MK, Mueller MJ, Sinacore DR, Salsich GB, Engsberg JR, Johnson JE. Effects of a tendo-Achilles lengthening procedure on muscle function and gait characteristics in a patient with diabetes mellitus. J Orthop Sports Phys Ther. 2000;30(2):85–90.
Maluf K, Mueller M, Strube M, Engsberg J, Johnson J. Tendon Achilles lengthening for the treatment of neuropathic ulcers causes a temporary reduction in forefoot pressure associated with changes in plantar flexor power rather than ankle motion during gait. J Biomech. 2004;37(6):897–906.
Grant WP, Sullivan R, Sonenshine DE, Stansberry KB, Moss QE, Peppard HR, Mcnitt PM, Vinik AI: Treatment of Charcot neuroarthropathy with Achilles tendon lengthening. Diabetes 1999, 48(5):SA401-SA401.
van der Ven A, Chapman CB, Bowker JH. Charcot neuroarthropathy of the foot and ankle. J Am Acad Orthop Surg. 2009;17(9):562–71.
Chantelau E, Poll L. Evaluation of the diabetic Charcot foot by MR imaging or plain radiography-an observational study. Exp Clin Endocrinol Diabetes. 2006;114(08):428–31.
We thank the research assistants from Mulago National Referral Hospital who helped recruited participants and collected blood samples.
The study was self-funded.
Ethics approval and consent to participate
The study was carried out after approval of school of medicine research and ethics committee (Ref: #REC REF 2017–090) and Mulago Hospital Research and ethics committee (MREC 18/10/2017). Written informed consent was obtained. Confidentiality from all the patients involved in the study was assured. Those diagnosed with CA were referred to the appropriate medical personnel.
Consent for publication
This paper is published with the approval of all the patients from which data were collected.
The authors declare that they have no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Wanzou, J.P.V., Sekimpi, P., Komagum, J.O. et al. Charcot arthropathy of the diabetic foot in a sub-Saharan tertiary hospital: a cross-sectional study. J Foot Ankle Res 12, 33 (2019) doi:10.1186/s13047-019-0343-0
- Charcot foot arthropathy
- Diabetic foot